HealthDay News — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Learn about the FDA's review of the safety of RSV prevention drugs Clesrovimab and Nirsevimab for infants and toddlers. Find ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Dr. Danielle Dhaliwal, the medical director of the pediatric ICU at Rocky Mountain Hospital for Children, joins us to talk ...

Pregnancy weakens your immune system, making flu, COVID-19, and RSV more dangerous. Learn the risks and how to protect ...

The FDA has informed Merck, Sanofi and AstraZeneca of the safety investigation into their RSV antibodies, though it remains ...

FDA officials have opened a safety review of two injectable RSV drugs used to protect babies and toddlers from the ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...